520 related articles for article (PubMed ID: 25994901)
1. Bioactive self-assembling lipid-like peptides as permeation enhancers for oral drug delivery.
Karavasili C; Spanakis M; Papagiannopoulou D; Vizirianakis IS; Fatouros DG; Koutsopoulos S
J Pharm Sci; 2015 Jul; 104(7):2304-11. PubMed ID: 25994901
[TBL] [Abstract][Full Text] [Related]
2. N-sulfonato-N,O-carboxymethylchitosan: a novel polymeric absorption enhancer for the oral delivery of macromolecules.
Thanou M; Henderson S; Kydonieus A; Elson C
J Control Release; 2007 Feb; 117(2):171-8. PubMed ID: 17184870
[TBL] [Abstract][Full Text] [Related]
3. A mucoadhesive nanoparticulate system for the simultaneous delivery of macromolecules and permeation enhancers to the intestinal mucosa.
Makhlof A; Werle M; Tozuka Y; Takeuchi H
J Control Release; 2011 Jan; 149(1):81-8. PubMed ID: 20138935
[TBL] [Abstract][Full Text] [Related]
4. Impact of amino acid replacements on in vitro permeation enhancement and cytotoxicity of the intestinal absorption promoter, melittin.
Maher S; Devocelle M; Ryan S; McClean S; Brayden DJ
Int J Pharm; 2010 Mar; 387(1-2):154-60. PubMed ID: 20025949
[TBL] [Abstract][Full Text] [Related]
5. Permeation enhancement via thiolation: in vitro and ex vivo evaluation of hyaluronic acid-cysteine ethyl ester.
Laffleur F; Psenner J; Suchaoin W
J Pharm Sci; 2015 Jul; 104(7):2153-60. PubMed ID: 25900642
[TBL] [Abstract][Full Text] [Related]
6. Sodium caprate-induced increases in intestinal permeability and epithelial damage are prevented by misoprostol.
Brayden DJ; Maher S; Bahar B; Walsh E
Eur J Pharm Biopharm; 2015 Aug; 94():194-206. PubMed ID: 26026287
[TBL] [Abstract][Full Text] [Related]
7. Microcontainers for oral insulin delivery - In vitro studies of permeation enhancement.
Jørgensen JR; Jepsen ML; Nielsen LH; Dufva M; Nielsen HM; Rades T; Boisen A; Müllertz A
Eur J Pharm Biopharm; 2019 Oct; 143():98-105. PubMed ID: 31425857
[TBL] [Abstract][Full Text] [Related]
8. Nanoparticles based on N-trimethylchitosan: evaluation of absorption properties using in vitro (Caco-2 cells) and ex vivo (excised rat jejunum) models.
Sandri G; Bonferoni MC; Rossi S; Ferrari F; Gibin S; Zambito Y; Di Colo G; Caramella C
Eur J Pharm Biopharm; 2007 Jan; 65(1):68-77. PubMed ID: 16962751
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and toxicity screening of various absorption enhancers using Caco-2 cell monolayers.
Quan YS; Hattori K; Lundborg E; Fujita T; Murakami M; Muranishi S; Yamamoto A
Biol Pharm Bull; 1998 Jun; 21(6):615-20. PubMed ID: 9657048
[TBL] [Abstract][Full Text] [Related]
10. Lipid-like self-assembling peptide nanovesicles for drug delivery.
Fatouros DG; Lamprou DA; Urquhart AJ; Yannopoulos SN; Vizirianakis IS; Zhang S; Koutsopoulos S
ACS Appl Mater Interfaces; 2014 Jun; 6(11):8184-9. PubMed ID: 24821330
[TBL] [Abstract][Full Text] [Related]
11. HEC-cysteamine particles: influence of particle size, zeta potential, morphology and sulfhydryl groups on permeation enhancing properties.
Rahmat D; Müller C; Shahnaz G; Leithner K; Laffleur F; Khan MI; Martien R; Bernkop Schnürch A
Drug Dev Ind Pharm; 2013 Sep; 39(9):1338-45. PubMed ID: 22901004
[TBL] [Abstract][Full Text] [Related]
12. Melittin as an epithelial permeability enhancer I: investigation of its mechanism of action in Caco-2 monolayers.
Maher S; Feighery L; Brayden DJ; McClean S
Pharm Res; 2007 Jul; 24(7):1336-45. PubMed ID: 17373574
[TBL] [Abstract][Full Text] [Related]
13. N-trimethyl chitosan chloride as a potential absorption enhancer across mucosal surfaces: in vitro evaluation in intestinal epithelial cells (Caco-2).
Kotzé AF; Luessen HL; de Leeuw BJ; de Boer BG; Verhoef JC; Junginger HE
Pharm Res; 1997 Sep; 14(9):1197-202. PubMed ID: 9327448
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of intestinal absorption of macromolecules by spermine in rats.
Sugita Y; Takao K; Toyama Y; Shirahata A
Amino Acids; 2007 Aug; 33(2):253-60. PubMed ID: 17653818
[TBL] [Abstract][Full Text] [Related]
15. Intestinal permeation enhancers enable oral delivery of macromolecules up to 70 kDa in size.
Fein KC; Gleeson JP; Newby AN; Whitehead KA
Eur J Pharm Biopharm; 2022 Jan; 170():70-76. PubMed ID: 34879228
[TBL] [Abstract][Full Text] [Related]
16. Combining Chemical Permeation Enhancers for Synergistic Effects.
du Toit T; Malan MM; Lemmer HJ; Gouws C; Aucamp ME; Breytenbach WJ; Hamman JH
Eur J Drug Metab Pharmacokinet; 2016 Oct; 41(5):575-86. PubMed ID: 25939330
[TBL] [Abstract][Full Text] [Related]
17. Mycophenolic acid mediated disruption of the intestinal epithelial tight junctions.
Qasim M; Rahman H; Ahmed R; Oellerich M; Asif AR
Exp Cell Res; 2014 Apr; 322(2):277-89. PubMed ID: 24509232
[TBL] [Abstract][Full Text] [Related]
18. Absorption-enhancing effects of gemini surfactant on the intestinal absorption of poorly absorbed hydrophilic drugs including peptide and protein drugs in rats.
Alama T; Kusamori K; Katsumi H; Sakane T; Yamamoto A
Int J Pharm; 2016 Feb; 499(1-2):58-66. PubMed ID: 26707414
[TBL] [Abstract][Full Text] [Related]
19. In vitro evaluation of liposomes containing bio-enhancers for the oral delivery of macromolecules.
Parmentier J; Hartmann FJ; Fricker G
Eur J Pharm Biopharm; 2010 Nov; 76(3):394-403. PubMed ID: 20849953
[TBL] [Abstract][Full Text] [Related]
20. Labrasol
Heade J; Maher S; Bleiel SB; Brayden DJ
J Pharm Sci; 2018 Jun; 107(6):1648-1655. PubMed ID: 29462634
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]